OBS-CURE: An oligometastatic breast cancer registry – are we already curing metastatic disease?

    NAME OBS-CURE
    CANCER TYPE Breast cancer
    INSTITUTION Olivia-Newton John Cancer Research Institute
    STATE Victoria
    GRANT TYPE $100,000
    PROJECT TYPE Support

    "This observational study will create a national registry for patients with very limited metastatic breast cancer (called “oligometastatic disease”). It aims to identify patients who may be cured with multimodality therapy. Ultimately this study can help to establish national guidelines on how to best treat this special population of patients.

    Dr Belinda Yeo, researcher at Olivia Newton-John Research Institute